The False Claims Act's Seal Provisions Upheld
Client Alert | 1 min read | 04.04.11
The False Claims Act contains seal provisions that require every qui tam complaint to be filed under seal for a 60-day period, which is often extended many times over, to give the Department of Justice an opportunity to investigate the allegations and intervene, if it chooses. In ACLU v. Holder (Mar. 28, 2011, http://pacer.ca4.uscourts.gov/opinion.pdf/092086.P.pdf), the Fourth Circuit, in a 2-1 decision, rejected arguments that these provisions violate the public’s First Amendment right of access to judicial proceedings or infringe the authority of federal courts to decide whether a particular complaint should be unsealed in violation of the Constitution’s separation of powers clause, noting that the seal provisions are narrowly tailored because, inter alia, relators are precluded only from publicly discussing the filing of the suit and not from disclosing the existence of the fraud.
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry
